 | • レポートコード：MRC2-11QY11040 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は分岐部病変のグローバル市場について調査・分析したレポートです。種類別（ワンステント、ツーステント）市場規模、用途別（冠状血管、末梢血管）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別分岐部病変の競争状況、市場シェア ・世界の分岐部病変市場：種類別市場規模 2015年-2020年（ワンステント、ツーステント） ・世界の分岐部病変市場：種類別市場規模予測 2021年-2026年（ワンステント、ツーステント） ・世界の分岐部病変市場：用途別市場規模 2015年-2020年（冠状血管、末梢血管） ・世界の分岐部病変市場：用途別市場規模予測 2021年-2026年（冠状血管、末梢血管） ・北米の分岐部病変市場分析：米国、カナダ ・ヨーロッパの分岐部病変市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの分岐部病変市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の分岐部病変市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの分岐部病変市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Boston Scientific Corporation、Abbott、Cardinal Health、Medtronic、C. R. Bard, Inc.、Johnson & Johnson Services, Inc.、Spectranetics、Terumo Medical Corporation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A artery narrowing occuring adjacent to,
and/or involving, the origin of a significant side
branch.
North America dominated the bifurcation lesions market in 2016. The region is expected to maintain its dominance during the forecast period. This can be attributed to local presence of major market players, higher disposable income, and favorable reimbursement policies.
Market Analysis and Insights: Global Bifurcation Lesions Market
The global Bifurcation Lesions market size is projected to reach US$ 1677.6 million by 2026, from US$ 1621.9 million in 2020, at a CAGR of 3.2%% during 2021-2026.
Global Bifurcation Lesions Scope and Market Size
Bifurcation Lesions market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bifurcation Lesions market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Boston Scientific Corporation
Abbott
Cardinal Health
Medtronic
C. R. Bard, Inc.
Johnson & Johnson Services, Inc.
Spectranetics
Terumo Medical Corporation
Market segment by Type, the product can be split into
One-Stent
Two-Stent
Market segment by Application, split into
Coronary Vascular
Peripheral Vascular
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Bifurcation Lesions Revenue
1.4 Market by Type
1.4.1 Global Bifurcation Lesions Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 One-Stent
1.4.3 Two-Stent
1.5 Market by Application
1.5.1 Global Bifurcation Lesions Market Share by Application: 2020 VS 2026
1.5.2 Coronary Vascular
1.5.3 Peripheral Vascular
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Bifurcation Lesions Market Perspective (2015-2026)
2.2 Global Bifurcation Lesions Growth Trends by Regions
2.2.1 Bifurcation Lesions Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bifurcation Lesions Historic Market Share by Regions (2015-2020)
2.2.3 Bifurcation Lesions Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Bifurcation Lesions Market Growth Strategy
2.3.6 Primary Interviews with Key Bifurcation Lesions Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Bifurcation Lesions Players by Market Size
3.1.1 Global Top Bifurcation Lesions Players by Revenue (2015-2020)
3.1.2 Global Bifurcation Lesions Revenue Market Share by Players (2015-2020)
3.1.3 Global Bifurcation Lesions Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Bifurcation Lesions Market Concentration Ratio
3.2.1 Global Bifurcation Lesions Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Bifurcation Lesions Revenue in 2019
3.3 Bifurcation Lesions Key Players Head office and Area Served
3.4 Key Players Bifurcation Lesions Product Solution and Service
3.5 Date of Enter into Bifurcation Lesions Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bifurcation Lesions Historic Market Size by Type (2015-2020)
4.2 Global Bifurcation Lesions Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Bifurcation Lesions Market Size by Application (2015-2020)
5.2 Global Bifurcation Lesions Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bifurcation Lesions Market Size (2015-2020)
6.2 Bifurcation Lesions Key Players in North America (2019-2020)
6.3 North America Bifurcation Lesions Market Size by Type (2015-2020)
6.4 North America Bifurcation Lesions Market Size by Application (2015-2020)
7 Europe
7.1 Europe Bifurcation Lesions Market Size (2015-2020)
7.2 Bifurcation Lesions Key Players in Europe (2019-2020)
7.3 Europe Bifurcation Lesions Market Size by Type (2015-2020)
7.4 Europe Bifurcation Lesions Market Size by Application (2015-2020)
8 China
8.1 China Bifurcation Lesions Market Size (2015-2020)
8.2 Bifurcation Lesions Key Players in China (2019-2020)
8.3 China Bifurcation Lesions Market Size by Type (2015-2020)
8.4 China Bifurcation Lesions Market Size by Application (2015-2020)
9 Japan
9.1 Japan Bifurcation Lesions Market Size (2015-2020)
9.2 Bifurcation Lesions Key Players in Japan (2019-2020)
9.3 Japan Bifurcation Lesions Market Size by Type (2015-2020)
9.4 Japan Bifurcation Lesions Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Bifurcation Lesions Market Size (2015-2020)
10.2 Bifurcation Lesions Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Bifurcation Lesions Market Size by Type (2015-2020)
10.4 Southeast Asia Bifurcation Lesions Market Size by Application (2015-2020)
11 India
11.1 India Bifurcation Lesions Market Size (2015-2020)
11.2 Bifurcation Lesions Key Players in India (2019-2020)
11.3 India Bifurcation Lesions Market Size by Type (2015-2020)
11.4 India Bifurcation Lesions Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Bifurcation Lesions Market Size (2015-2020)
12.2 Bifurcation Lesions Key Players in Central & South America (2019-2020)
12.3 Central & South America Bifurcation Lesions Market Size by Type (2015-2020)
12.4 Central & South America Bifurcation Lesions Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Boston Scientific Corporation
13.1.1 Boston Scientific Corporation Company Details
13.1.2 Boston Scientific Corporation Business Overview
13.1.3 Boston Scientific Corporation Bifurcation Lesions Introduction
13.1.4 Boston Scientific Corporation Revenue in Bifurcation Lesions Business (2015-2020))
13.1.5 Boston Scientific Corporation Recent Development
13.2 Abbott
13.2.1 Abbott Company Details
13.2.2 Abbott Business Overview
13.2.3 Abbott Bifurcation Lesions Introduction
13.2.4 Abbott Revenue in Bifurcation Lesions Business (2015-2020)
13.2.5 Abbott Recent Development
13.3 Cardinal Health
13.3.1 Cardinal Health Company Details
13.3.2 Cardinal Health Business Overview
13.3.3 Cardinal Health Bifurcation Lesions Introduction
13.3.4 Cardinal Health Revenue in Bifurcation Lesions Business (2015-2020)
13.3.5 Cardinal Health Recent Development
13.4 Medtronic
13.4.1 Medtronic Company Details
13.4.2 Medtronic Business Overview
13.4.3 Medtronic Bifurcation Lesions Introduction
13.4.4 Medtronic Revenue in Bifurcation Lesions Business (2015-2020)
13.4.5 Medtronic Recent Development
13.5 C. R. Bard, Inc.
13.5.1 C. R. Bard, Inc. Company Details
13.5.2 C. R. Bard, Inc. Business Overview
13.5.3 C. R. Bard, Inc. Bifurcation Lesions Introduction
13.5.4 C. R. Bard, Inc. Revenue in Bifurcation Lesions Business (2015-2020)
13.5.5 C. R. Bard, Inc. Recent Development
13.6 Johnson & Johnson Services, Inc.
13.6.1 Johnson & Johnson Services, Inc. Company Details
13.6.2 Johnson & Johnson Services, Inc. Business Overview
13.6.3 Johnson & Johnson Services, Inc. Bifurcation Lesions Introduction
13.6.4 Johnson & Johnson Services, Inc. Revenue in Bifurcation Lesions Business (2015-2020)
13.6.5 Johnson & Johnson Services, Inc. Recent Development
13.7 Spectranetics
13.7.1 Spectranetics Company Details
13.7.2 Spectranetics Business Overview
13.7.3 Spectranetics Bifurcation Lesions Introduction
13.7.4 Spectranetics Revenue in Bifurcation Lesions Business (2015-2020)
13.7.5 Spectranetics Recent Development
13.8 Terumo Medical Corporation
13.8.1 Terumo Medical Corporation Company Details
13.8.2 Terumo Medical Corporation Business Overview
13.8.3 Terumo Medical Corporation Bifurcation Lesions Introduction
13.8.4 Terumo Medical Corporation Revenue in Bifurcation Lesions Business (2015-2020)
13.8.5 Terumo Medical Corporation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Bifurcation Lesions Key Market Segments
Table 2. Key Players Covered: Ranking by Bifurcation Lesions Revenue
Table 3. Ranking of Global Top Bifurcation Lesions Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Bifurcation Lesions Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of One-Stent
Table 6. Key Players of Two-Stent
Table 7. Global Bifurcation Lesions Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Bifurcation Lesions Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Bifurcation Lesions Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Bifurcation Lesions Market Share by Regions (2015-2020)
Table 11. Global Bifurcation Lesions Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Bifurcation Lesions Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Bifurcation Lesions Market Growth Strategy
Table 17. Main Points Interviewed from Key Bifurcation Lesions Players
Table 18. Global Bifurcation Lesions Revenue by Players (2015-2020) (Million US$)
Table 19. Global Bifurcation Lesions Market Share by Players (2015-2020)
Table 20. Global Top Bifurcation Lesions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bifurcation Lesions as of 2019)
Table 21. Global Bifurcation Lesions by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Bifurcation Lesions Product Solution and Service
Table 24. Date of Enter into Bifurcation Lesions Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Bifurcation Lesions Market Size by Type (2015-2020) (Million US$)
Table 27. Global Bifurcation Lesions Market Size Share by Type (2015-2020)
Table 28. Global Bifurcation Lesions Revenue Market Share by Type (2021-2026)
Table 29. Global Bifurcation Lesions Market Size Share by Application (2015-2020)
Table 30. Global Bifurcation Lesions Market Size by Application (2015-2020) (Million US$)
Table 31. Global Bifurcation Lesions Market Size Share by Application (2021-2026)
Table 32. North America Key Players Bifurcation Lesions Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Bifurcation Lesions Market Share (2019-2020)
Table 34. North America Bifurcation Lesions Market Size by Type (2015-2020) (Million US$)
Table 35. North America Bifurcation Lesions Market Share by Type (2015-2020)
Table 36. North America Bifurcation Lesions Market Size by Application (2015-2020) (Million US$)
Table 37. North America Bifurcation Lesions Market Share by Application (2015-2020)
Table 38. Europe Key Players Bifurcation Lesions Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Bifurcation Lesions Market Share (2019-2020)
Table 40. Europe Bifurcation Lesions Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Bifurcation Lesions Market Share by Type (2015-2020)
Table 42. Europe Bifurcation Lesions Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Bifurcation Lesions Market Share by Application (2015-2020)
Table 44. China Key Players Bifurcation Lesions Revenue (2019-2020) (Million US$)
Table 45. China Key Players Bifurcation Lesions Market Share (2019-2020)
Table 46. China Bifurcation Lesions Market Size by Type (2015-2020) (Million US$)
Table 47. China Bifurcation Lesions Market Share by Type (2015-2020)
Table 48. China Bifurcation Lesions Market Size by Application (2015-2020) (Million US$)
Table 49. China Bifurcation Lesions Market Share by Application (2015-2020)
Table 50. Japan Key Players Bifurcation Lesions Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Bifurcation Lesions Market Share (2019-2020)
Table 52. Japan Bifurcation Lesions Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Bifurcation Lesions Market Share by Type (2015-2020)
Table 54. Japan Bifurcation Lesions Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Bifurcation Lesions Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Bifurcation Lesions Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Bifurcation Lesions Market Share (2019-2020)
Table 58. Southeast Asia Bifurcation Lesions Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Bifurcation Lesions Market Share by Type (2015-2020)
Table 60. Southeast Asia Bifurcation Lesions Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Bifurcation Lesions Market Share by Application (2015-2020)
Table 62. India Key Players Bifurcation Lesions Revenue (2019-2020) (Million US$)
Table 63. India Key Players Bifurcation Lesions Market Share (2019-2020)
Table 64. India Bifurcation Lesions Market Size by Type (2015-2020) (Million US$)
Table 65. India Bifurcation Lesions Market Share by Type (2015-2020)
Table 66. India Bifurcation Lesions Market Size by Application (2015-2020) (Million US$)
Table 67. India Bifurcation Lesions Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Bifurcation Lesions Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Bifurcation Lesions Market Share (2019-2020)
Table 70. Central & South America Bifurcation Lesions Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Bifurcation Lesions Market Share by Type (2015-2020)
Table 72. Central & South America Bifurcation Lesions Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Bifurcation Lesions Market Share by Application (2015-2020)
Table 74. Boston Scientific Corporation Company Details
Table 75. Boston Scientific Corporation Business Overview
Table 76. Boston Scientific Corporation Product
Table 77. Boston Scientific Corporation Revenue in Bifurcation Lesions Business (2015-2020) (Million US$)
Table 78. Boston Scientific Corporation Recent Development
Table 79. Abbott Company Details
Table 80. Abbott Business Overview
Table 81. Abbott Product
Table 82. Abbott Revenue in Bifurcation Lesions Business (2015-2020) (Million US$)
Table 83. Abbott Recent Development
Table 84. Cardinal Health Company Details
Table 85. Cardinal Health Business Overview
Table 86. Cardinal Health Product
Table 87. Cardinal Health Revenue in Bifurcation Lesions Business (2015-2020) (Million US$)
Table 88. Cardinal Health Recent Development
Table 89. Medtronic Company Details
Table 90. Medtronic Business Overview
Table 91. Medtronic Product
Table 92. Medtronic Revenue in Bifurcation Lesions Business (2015-2020) (Million US$)
Table 93. Medtronic Recent Development
Table 94. C. R. Bard, Inc. Company Details
Table 95. C. R. Bard, Inc. Business Overview
Table 96. C. R. Bard, Inc. Product
Table 97. C. R. Bard, Inc. Revenue in Bifurcation Lesions Business (2015-2020) (Million US$)
Table 98. C. R. Bard, Inc. Recent Development
Table 99. Johnson & Johnson Services, Inc. Company Details
Table 100. Johnson & Johnson Services, Inc. Business Overview
Table 101. Johnson & Johnson Services, Inc. Product
Table 102. Johnson & Johnson Services, Inc. Revenue in Bifurcation Lesions Business (2015-2020) (Million US$)
Table 103. Johnson & Johnson Services, Inc. Recent Development
Table 104. Spectranetics Company Details
Table 105. Spectranetics Business Overview
Table 106. Spectranetics Product
Table 107. Spectranetics Revenue in Bifurcation Lesions Business (2015-2020) (Million US$)
Table 108. Spectranetics Recent Development
Table 109. Terumo Medical Corporation Business Overview
Table 110. Terumo Medical Corporation Product
Table 111. Terumo Medical Corporation Company Details
Table 112. Terumo Medical Corporation Revenue in Bifurcation Lesions Business (2015-2020) (Million US$)
Table 113. Terumo Medical Corporation Recent Development
Table 114. Research Programs/Design for This Report
Table 115. Key Data Information from Secondary Sources
Table 116. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bifurcation Lesions Market Share by Type: 2020 VS 2026
Figure 2. One-Stent Features
Figure 3. Two-Stent Features
Figure 4. Global Bifurcation Lesions Market Share by Application: 2020 VS 2026
Figure 5. Coronary Vascular Case Studies
Figure 6. Peripheral Vascular Case Studies
Figure 7. Bifurcation Lesions Report Years Considered
Figure 8. Global Bifurcation Lesions Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Bifurcation Lesions Market Share by Regions: 2020 VS 2026
Figure 10. Global Bifurcation Lesions Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Bifurcation Lesions Market Share by Players in 2019
Figure 13. Global Top Bifurcation Lesions Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bifurcation Lesions as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Bifurcation Lesions Revenue in 2019
Figure 15. North America Bifurcation Lesions Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Bifurcation Lesions Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Bifurcation Lesions Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Bifurcation Lesions Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Bifurcation Lesions Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Bifurcation Lesions Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Bifurcation Lesions Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
分岐部病変治療の世界市場（～2026年） Market Analysis and Insights: Global Bifurcation Lesions Treatment Market The global Bifurcation Lesions Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Bifurcation Lesions Treatment Scope and Market Size Bif…- 末梢血管診断システムの世界市場（～2026年） The cardiovascular system is a closed vascular system consisting of the heart and blood vessels. The increasing availability of specialized cardiology and vascular specialists across the globe will drive the growth prospects for the global peripheral vascular diagnostic systems market until the end …
- 末梢血管インターベンションの世界市場（～2026年） Market Analysis and Insights: Global Peripheral Vascular Interventions Market The global Peripheral Vascular Interventions market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Peripheral Vascular Interventions Scope and Mar…
- 前立腺ステントの世界市場（～2026年） Market Analysis and Insights: Global Prostate Stent Market The global Prostate Stent market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Stent Scope and Market Size Prostate Stent market is segmented by Type, and …
- 経皮的冠動脈インターベンションの世界市場（～2026年） Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visual…